Mark A. Glickman
CIK: 0001441461
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Glickman Mark A
Glickman Mark A (SEC CIK 0001441461) files insider reports with the SEC as Director of BioStem Technologies, Inc. (BSEM) and Director of MetaVia Inc. (MTVA).
Signal8 holds 4 ownership filings by Glickman Mark A (1 Form 3, 3 Form 4), filed between Jul 1, 2025 and Aug 28, 2026. Those filings report 3 transactions, from Jun 30, 2025 to Aug 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Glickman Mark A's filings is in POMPANO BEACH, FL.
Recent filings by Glickman Mark A
Other insiders filing for BioStem Technologies, Inc. (BSEM)
- SMITH-VAN VURST ANDREW, Chief Operating Officer
- Matuszewski Jason, Chief Executive Officer
- POE BRANDON, Chief Financial Officer
- WARRINGTON KENNETH HOWARD JR, Director
- FORTUNATO MICHAEL A, Chief Accounting Officer
- HASSETT BARRY, Chief Commercial Officer